Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer

Radiotherapy and Oncology

Volumn 71, Issue 2, 2004, Pages 139-146

  Senan, Suresh ^a   De Ruysscher, Dirk ^b   Giraud, Philippe ^c   Mirimanoff, René ^d   Budach, Volker ^e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUT CURIE   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Conformal radiotherapy; Literature based recommendations; Lung cancer; Publications

Indexed keywords

BRONCHUS CANCER; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGITIS; HEART DISEASE; HUMAN; LUNG CANCER; LUNG PARENCHYMA; LUNG TUMOR; PATIENT POSITIONING; PERICARDIAL DISEASE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; REVIEW; RISK FACTOR; SCORING SYSTEM; TREATMENT PLANNING;

EID: 1942478491     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.09.007     Document Type: Article

References (75)

1. Armstrong J.G., Burman C., Leibel S., et al. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys. 26:1993;685-689.
2. Balter J.M., Ten Haken R.K., Lawrence T.S., Lam K.L., Robertson J.M. Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing. Int J Radiat Oncol Biol Phys. 36:1996;167-174.
3. Belderbos J.S., De Jaeger K., Heemsbergen W.D., et al. Interim analysis of a phase I/II dose escalation trial in non-small cell lung cancer (NSCLC) using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 51:2001;S2232. Abstr.
4. Bradley J., Deasy J., Bentzen S.M., Bosch W., Purdy J. Irradiated esophageal surface area predicts for esophagitis in patients treated for non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 54:(S2):2002;199. abstract 177.
5. Brugmans M.J., Van der Horst A., Lebesque J.V., Mijnheer B.J. Beam intensity modulation to reduce the field sizes for conformal irradiation of lung tumors: a dosimetric study. Int J Radiat Oncol Biol Phys. 43:1999;893-904.
6. Buy J.N., Ghossain M.A., Poirson F., et al. Computed tomography of mediastinal lymph nodes in non small cell lung cancer. J Comput Assist Tomogr. 12:1988;545-552.
7. Cascade P.N., Gross B.H., Kazbraoni E.A., et al. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT. Am J Radiol. 170:1998;927-931.
8. Choy H., La Porte K., Knill-Selby E., Mohr P., Shyr Y. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. Semin Radiat Oncol. 9:1999;90-96.
9. De Boer H.C., van Sornsen de Koste J.R., Senan S., et al. Analysis and reduction of 3D systematic and random setup errors during the simulation and treatment of lung cancer patients with CT-based dose planning. Int J Radiat Oncol Biol Phys. 49:2001;857-868.
10. Dwamena B.A., Sonnad S.S., Angobaldo J., Wahl R.L. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - meta-analytic comparison of PET and CT. Radiology. 213:1999;530-536.
11. Ford E.C., Mageras G.S., Yorke E., Ling C.C. Respiration-correlated spiral CT: a method of measuring respiratory-induced anatomic motion for radiation treatment planning. Med Phys. 30:2003;88-97.
12. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol. 17:1999;2692-2699.
13. Graham M.V., Purdy J.A., Emami B., Matthews J.W., Harms W.B. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 33:1995;993-1000.
14. Graham M.V., Purdy J.A., Emamai B., et al. Clinical DVH analysis for pneumonitis after 3D treatment NSCLC. Int J Radiat Oncol Biol Phys. 45:1999;323-329.
15. Graham M.V., Winter K., Purdy J.A., et al. Preliminary results of RTOG 9311, a dose escalation study using 3D conformal radiation therapy in patients with inoperable NSCLC. Int J Radiat Oncol Biol Phys. 51:2001;S3. Abstr.
16. Giraud P. Influence of CT images visualization parameters for target volume delineation in lung cancer. Proceeding of 19th ESTRO Istanbul, 2000. Radiother Oncol. S39:2000.
17. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 48:2000;1015-1024.
18. 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys. 50:2001;1249-1257.
19. Giraud P., De Rycke Y., Dubray B., et al. Conformal radiotherapy planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing. Int J Radiat Oncol Biol Phys. 51:2001;1081-1092.
20. Giraud P., Elles S., Helfre S., et al. Conformal radiotherapy for lung cancer: different delineation of the GTV by radiologists and radiation oncologists. Radiother Oncol. 62:2001;27-36.
21. Glazer G.M., Gross B.H., Quint L.E., Francis I.R., Bookstein F.L., Orringer M.B. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. Am J Roentgenol. 144:1985;261-265.
22. Goerres G.W., Karnel E., Heidelberg T.N., Schwitter M.R., Burger C., von Schulthess G.K. PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med. 29:2002;351-360.
23. Green M.R., Ginsberg R., Ardizzoni A., et al. Induction therapy for stage III NSCLC: a consensus report. Lung Cancer. 11:(Suppl 3):1994;9-10.
24. Halperin R., Roa W., Field M., Hanson J., Murray B. Setup reproducibility in radiation therapy for lung cancer: a comparison between T-bar and expanded foam immobilization devices. Int J Radiat Oncol Biol Phys. 43:1999;211-216.
25. Halperin R., Pobinson D., Murray B. Fluoroscopy for assessment of physiologic movement of lung tumors, a pitfall of clinical practice? Proceeding of Innovative Technology in Radiation Medicine Toronto, October 22-27. Radiother Oncol. 65:2002;s1. abstract 87.
26. Hara R., Itami J., Kondo T., et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol. 63:2002;159-163.
27. Harris K.M., Adams H., Lloyd D.C., et al. The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings. Clin Radiol. 47:(4):1993;241-244.
28. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol. 19:2001;127-136.
29. Hirota S., Tsujino K., Endo M., et al. Dosimetric predictors of radiation esophagitis in patients treated for NSCLC with carboplatin/paclitaxel/ radiotherapy. Int J Radiat Oncol Biol Phys. 1:2001;291-295.
30. http://ctep.cancer.gov/reporting/ctc.html.
31. Kiyono K., Sone S., Sakai F., et al. The number and size of normal mediastinal lymph nodes: a postmortem study. Am J Radiol. 150:1988;771-776.
32. Komaki R., Seiferheld W., Curran W., et al. Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer: analysis of failures in a phase III study (RTOG 9410). Int J Radiat Oncol Biol Phys. 5:2001;S5. Abstr.
33. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 42:1998;1-9.
34. Lagerwaard F.J., van Sornsen de Koste J.R., Nijssen-Visser M.R., et al. Multiple slow CT scans for incorporating lung tumor mobility in radiotherapy planning. Int J Radiat Oncol Biol Phys. 51:2001;932-937.
35. Lagerwaard F.J., van de Vaart P.J.M., Voet P.W.J., et al. Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer? Lung Cancer. 38:2002;297-301.
36. Maguire P.D., Sibley G.S., Zhou S.M., et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys. 45:1999;97-103.
37. 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys. 52:2002;339-350.
38. McGibney C., Holmberg O., McClean B., et al. Dose escalation of chart in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary? Int J Radiat Oncol Biol Phys. 45:1999;339-350.
39. McGibney C. Impact of intravenous contrast on target definition in radiotherapy of non small cell lung cancer. Eur J Cancer. 37:(Suppl 6):2001;211.
40. McNee S.G., Rampling R., Dale A.J., Gregor A. An audit of 3-D treatment planning facilities and practice in the UK. Clin Oncol. 10:1998;18-23.
41. Mirimanoff R.O. Immobilization devices in conformal radiotherapy for non-small cell lung cancer. Mornex F., Van Houtte P. Treatment optimization for lung cancer: from classical to innovative procedures. 1998;103-108 Elsevier, Paris.
42. Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest. 111:1997;1718-1723.
43. Murphy M.J., Martin D., Whyte R., Hai J., Ozhasoglu C., Le Q.T. The effectiveness of breath-holding to stabilize lung and pancreas tumors during radiosurgery. Int J Radiat Oncol Biol Phys. 53:2002;475-482.
44. Patz E.F. Jr., Erasmus J.J., McAdams H.P., et al. Lung cancer staging and management: comparison of contrast-enhanced and non-enhanced helical CT of the thorax. Radiology. 212:1999;56-60.
45. Rosenman J., Halle J., Socinski M., Deschesne K., Moore D., Johnson H., Fraser R., Morris D. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. Int J Radiat Oncol Biol Phys. 54:2002;348-356.
46. Rosenzweig K., Hanley J., Mah D., et al. The deep inspiration breath-hold (DIBH) technique in the treatment of inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 48:2000;81-87.
47. Rosenzweig K.E., Sim S.E., Mychalczak B., Braban L.E., Schindelheim R., Leibel S.A. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 50:2001;681-685.
48. Samson M.J., van Sornsen de Koste J.R., de Boer H.C., et al. An analysis of anatomic landmark mobility and setup deviations in radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 43:1999;827-832.
49. Saunders M.I., Dische S., Barrett A., Harvey A., Gibson D., Parmar M.K.B., on behalf of the CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicenter trial. Lancet. 350:1997;161-165.
50. Sause W., Kolesar P., Taylor S., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest. 117:2000;358-364.
51. Schaake-Koning C., Van den Bogaert W., Dalesio O., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med. 326:1992;524-530.
52. Schuster-Uitterhoeve A.L., Hulshof M.C., Gonzalez Gonzalez D., Koolen M., Sminia P. Feasibility of curative radiotherapy with a concomitant boost technique in 33 patients with non-small cell lung cancer. Radiother Oncol. 28:1993;247-251.
53. Senan S., van Sornsen de Koste J.R., Samson M., et al. Evaluation of a target contouring protocol for 3-D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol. 53:1999;245-253.
54. Senan S., Burgers J.A., Samson M.J., et al. Can elective nodal irradiation can be omitted in stage III non-small cell lung cancer: an analysis of recurrences after sequential chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys. 54:2002;999-1006.
55. Seppenwoolde Y., Shirato H., Kitamura K., et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys. 53:2002;822-834.
56. Sibley G.S. Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: smaller volumes and higher doses - a review. Cancer. 82:1998;433-438.
57. Sorensen P., Hansen O. The location of recurrences in patients with non-small cell lung cancer treated with involved-field irradiation. Lung Cancer. 29:(S1):2000;S171. Abstr.
58. Stevens C.W., Munden R.F., Forster K.M., et al. Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function. Int J Radiat Oncol Biol Phys. 51:2001;62-68.
59. Stroom J.C., Korevaar G.A., Koper P.C., Visser A.G., Heijmen B.T. Multiple two-dimensional versus three-dimensional PTV definition in treatment planning for conformal radiotherapy. Radiother Oncol. 47:1998;297-302.
60. Stroom J.C., de Boer H.C., Huizenga H., Visser A.G. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. Int J Radiat Oncol Biol Phys. 43:1999;905-919.
61. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New citeria to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 92:2000;205-216.
62. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys. 55:2003;110-115.
63. Turrisi A.T. III, Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 340:1999;265-271.
64. Van de Steene J., Van den Heuvel F., Bel A., et al. Electronic portal imaging with on-line correction of setup error in thoracic irradiation: clinical evaluation. Int J Radiat Oncol Biol Phys. 40:1998;967-976.
65. Van Herk M., Remeijer P., Rasch C., Lebesque J.V. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;1121-1135.
66. Van Houtte P., Gregor A., Philips P. International survey of radiotherapy practice for radical treatment of non-small cell lung cancer. Lung Cancer. 3:1994;S129-S138.
67. van Sörnsen de Koste J.R., Voet P., Dirkx M., van Meerbeeck J.P., Senan S. An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer. Lung Cancer. 32:2001;145-153.
68. van Sörnsen de Koste J.R., Lagerwaard F.J., Nijssen-Visser M.R.J., Schuchhard-Schipper R., Joosten H., Senan S. Which margins are necessary for incorporating mediastinal nodal mobility in involved field radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys. 53:2002;115-119.
69. van Sörnsen de Koste J.R., de Boer H.C.J., Schuchhard-Schipper R.H., Senan S., Heijmen B.J.M. Procedures for high precision setup verification and correction of lung cancer patients using CT-simulation and digitally reconstructed radiographs. Int J Radiat Oncol Biol Phys. 55:2003;804-810.
70. van Sörnsen de Koste J.R., Lagerwaard F.J., Schuchhard-Schipper R.H., et al. Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer - an analysis of data generated using slow CT scans. Radiother Oncol. 61:2001;93-99.
71. van Sörnsen De Koste J.R. Are multiple CT scans required for planning curative radiotherapy in lung tumors of the lower lobe? Int J Radiat Oncol Biol Phys. 55:2003;1394-1399.
72. 18 F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol. 55:2000;317-324.
73. Vedam S.S., Keall P.J., Kini V.R., Mostafavi H., Shukla H.P., Mohan R. Acquiring a four-dimensional computed tomography dataset using an external respiratory signal. Phys Med Biol. 48:2003;45-62.
74. Werner-Wasik M., Pequignot E., Leeper D., Hauck W., Curran W. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys. 48:2000;689-696.
75. Wormanns D., Diederich S., Lentschig M.G., Winter F., Heindel W. Spiral CT of pulmonary nodules: interobserver variation in assessment of lesion size. Eur Radiol. 10:2000;710-713.